Based on the increase of NDKA within three hours of a stroke, this protein was proposed as a biomarker for the early diagnosis of stroke, with a sensitivity of 70–90% and a specificity of 90–97% [4, 7]. This evidence concerns the gene NME1 and stroke disorder.